Navigation Links
Building and Sustaining Impactful Competitive Intelligence Organizations for Pharma

CHAPEL HILL, N.C., Jan. 29 /PRNewswire/ -- In today's volatile business environment, unforeseen market shifts can blindside an unwary pharmaceutical company and nullify product forecasts, sales strategies and development plans. By delivering high-impact analyses on competitors' products and operations, a high-functioning Competitive Intelligence group can alert organizations to emerging market opportunities as well as warn them about potential external risks.

Competitive Intelligence groups in the pharma sector track an average of 23 competitors, according to new research by Best Practices, LLC. On the product side, the study found CI groups in pharma track an average of 49 products sold by competitors.

"An effective Competitive Intelligence group delivers guidance that gives a company a long-term competitive edge," said Cameron Tew, manager of research and publishing at Best Practices, LLC. "Both in terms of presenting opportunities and preparing for risks, the CI function provides key decision makers with actionable insights."

The cross-industry report, which presents data for the full benchmark class and pharmaceutical segment, is based on insights gathered from 54 organizations, with almost half of the companies from the pharmaceutical sector. Participants included Amgen, Eli Lilly, Roche, Sanofi-Aventis, Merck, Abbott and Wyeth.

A complimentary summary of "Building & Sustaining Impactful Competitive Intelligence Organizations" is available at .

The comprehensive study covers everything from creating and structuring a CI group to developing high-impact CI activities and effective stakeholder relationships. The benchmarking study includes more than 500 metrics, including staffing and salary metrics. In addition to helping executives understand how to build an effective CI program, the study presents proven methods for increasing the quality and value of an existing CI group.

Some of the sample findings of the report include:

-- Winning CI organizations tie their goals to corporate business

objectives to assure that their deliverables will inform executives on

key issues and, ultimately, drive profitability.

-- Strategic planning and business development are the departmental homes

where interviewed executives think CI should reside.

-- The average CI operating budget is $821,613, although budgets varied

widely across study participants. The average salary for a CI head is


Download additional findings in the complimentary report summary at: or contact our Solution Specialists at (919) 403-0251 or

If you would like to speak to us about how our research can benefit your Competitive Intelligence organization or other initiatives in your company, please contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or


Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 15 years; our clients include 43 out of the top 50 pharmaceutical companies.

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New insight into factors that drive muscle-building stem cells
2. Pain treatment in the field: Good for soldiers comfort and better for rebuilding troop strength
3. Seasonal Sippers Supply Bone-Building Benefits
4. Building Better Launch Teams for Pharmaceutical Commercialization Success
5. Hidden Costs Plague Owners Occupying Newly Constructed Buildings; New Program Can Help Avoid Major Issues
6. Buildings Across The Country Join St. Jude Childrens Research Hospital(R) For Fourth Annual Thanks and Giving(R) Campaign, Asking America To Help Save Childrens Lives While Shopping For The Holidays
7. Advances in drug screening: building a better haystack for the needles of tomorrow
8. Mirixa Debuts RxFYI - a Free Pharmacy-Published Health eNewsletter Building Patient Loyalty and Generating Revenue
9. Building efficient, effective, locally sensitive solutions for dementia care
10. Medical Affairs: Building Efficient Medical Affairs Functions That Drive Product Marketing Success
11. Siemens Building Technologies Pioneers Wireless Solution for St. Anthonys Sensitive Environment
Post Your Comments:
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from reveals that behind the tendency to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
Breaking Medicine Technology: